Back

Gender differences in mortality benefit of raas inhibitors in heart failure: a retrospective cohort study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Heart failure pharmacotherapy updates Angiotensin-Renin-Bradykinin System ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Viana Copeland

Chaim Sheba Medical Center, Tel Aviv Universty, Ramat Gan (Israel)

3 More presentations in this session

Presentation thumbnail
Safety and efficacy of potassium binders on hyperkalemia: a novel systematic review and meta-analysis of randomized controlled trials
Ms M. Werlang (Rio Do Sul, BR)
Abstract Slides Video
Presentation thumbnail
6 years of ARNI use in Israel - effectiveness analysis in real world data
Professor Z. Iakobishvili (Tel Aviv, IL)
Abstract Slides Video
Presentation thumbnail
Impact of sodium-glucose co-transporter 2 inhibition on right ventricular function and pulmonary artery systolic pressure across heart failure phenotypes: a meta-analytic approach
Doctor M. Patricio (Manila, PH)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure pharmacotherapy updates

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Hypertension and mortality risk in heart failure: a gender-specific analysis of HF subtypes
thumbnail
Congress Presentation
Does gender really affect the prognosis of heart failure patients with reduced ejection fraction?
thumbnail
Congress Session
Deeper phenotyping in heart failure: race- and sex-related differences

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources